SynthesisCell reports. Medicine2026
Suboptimal therapeutic responses associated with semaglutide in type 2 diabetes and obesity: A meta-analysis of randomized controlled trials.
Donghyun Ko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.